References
- Rehfeld J F. Three components of gastrin in serum. Biochim Biophys Acta 1972; 285: 364–72
- Gregory R A, Tracy H J. Isolation of two big gastrins from Zollinger‐Ellison tumour tissue. Lancet 1972; II: 797–9
- Gregory R A, Tracy H J. The constitution and properties of two gastrins extracted from hog antral mucosa. Gut 1964; 5: 103–17
- Rehfeld J F, Stadil F. Gel filtration studies on immunoreactive gastrin in serum from Zollinger‐Ellison patients. Gut 1973; 14: 369–73
- Gregory R A, Tracy H J, Harris J I, Runswick M J, Moore S, Kenner G W, Ramage R. Minigastrin: corrected structure and synthesis. Hoppe‐Seylers Z Physiol Chem 1979; 360: 73–80
- Andersen B N, Magistris Ld, Rehfeld J F. Radioimmunochemical quantitation of sulfated and non‐sulfated gastrins in biological fluids. Clin Chim Acta 1983; 127: 29–39
- Eysselein Y E, Maxwell V, Reedy T, Wünsch E, Walsh J H. Similar acid stimulatory potencies of synthetic human big and little gastrins in man. J Clin Invest 1984; 73: 1284–90
- Hirst B H, Holland J, Marr A P, Parsons M E, Sanders D J. Comparison of effect of peptide length and sulphation on acid secretory potency of gastrin in the cat in vivo and in vitro. J Physiol 1984; 357: 441–52
- Rehfeld J F, Andersen B N, Petersen B, Raaberg L, Schwartz T W, Stadil F. Misuse of gastrin radioimmunoassay kits. Lancet 1983; II: 338
- Rehfeld J F, Stadil F, Rubin B. Production and evaluation of antibodies for the radioimmunoassay of gastrin. Scand J Clin Lab Invest 1972; 30: 221–32
- Rehfeld J F, Magistris Ld, Andersen B N. Sulfation of gastrin: effect on immunoreactivity. Regul Pept 1981; 2: 333–42
- Wolfe M M, Paquet R J, Reel G M. Specificity of commercially available antibodies used for gastrin measurement. J Lab Clin Med 1985; 105: 417–21
- Stadil F, Rehfeld J F. Preparation of 125I‐labelled synthetic human gastrin I for radioimmunoanalysis. Scand J Clin Lab Invest 1972; 30: 361–8
- Stadil F, Rehfeld J F. Determination of gastrin in serum. An evaluation of the reliability of a radioimmunoassay. Scand J Gastroent 1973; 8: 101–12
- Zollinger R M, Coleman D W. The influences of pancreatic tumors on the stomach. CC Thomas Publ., Springfield, Illinois 1974; 1–205
- Said S I. Vasoactive Intestinal Polypeptide (VIP): isolation, distribution, biological action, structure‐function relationships, and possible function. Gastrointestinal Hormones, G BJ Glass. Raven Press, New York 1980; 245–73
- Howitz J, Rehfeld J F. Serum gastrin in vitiligo. Lancet 1974; I: 831–4
- Lindstedt G, Bengtsson C, Lapidus L, Nyström E. Hypergastrinemia—a risk factor for myocardial infarction. Clin Chem 1985; 31: 585–90
- Rehfeld J F, Stadil F, VinkelsØe J. Immunoreactive gastrin components in human serum. Gut 1974; 15: 102–11
- Andersen B N, Stadil F. Sulfation of gastrin in the Zollinger‐Ellison syndrome. Regul Pept 1983; 6: 231–9